GLOBAL Webinars April 2025

New Clinical Trials Targeting Alzheimer’s Disease in People with Down Syndrome

Overview

This informative GLOBAL Webinar discussed why people with Down syndrome are at high risk for developing Alzheimer’s disease; and information about how to get involved in clinical trials for Alzheimer’s disease in people with Down syndrome. 

The webinar attracted over 450 registrants from 50 states and 15 countries (Australia, Brazil, Canada, Finland, France, Iraq, Italy, Japan, Kenya, New Zealand, Pakistan, Scotland, Tunisia, Uganda, and United Kingdom).

PowerPoint Presentation: Click to Download

Michael S. Rafii, MD, PhD

Dr. Rafii is a board-certified neurologist, Professor of Clinical Neurology at the Keck School of Medicine and Medical Director of the Alzheimer’s Therapeutic Research Institute (ATRI).

Dr. Rafii is a physician-scientist whose research focuses on developing treatments for Alzheimer’s disease (AD) including a genetic form of AD that occurs in people with Down syndrome (DS). He is Principal Investigator of the NIH-funded Alzheimer’s Clinical Trials Consortium – Down Syndrome (ACTC-DS), an international network of over 20 expert sites conducting clinical trials for Alzheimer’s in people with Down syndrome. Dr. Rafii’s work has been featured in the New York Times, Chicago Tribune, Washington Post, Wall Street Journal and on National Public Radio (NPR).

The presentation with audio as well as your questions and answers can be accessed using your GLOBAL Membership code. Not a Member? Join today! THANK YOU for supporting GLOBAL and our important work!

This webinar is one of the many benefits associated with Global Down Syndrome Foundation Membership. Learn more about GLOBAL’s award-winning magazine, Down Syndrome World™, and how to become a GLOBAL Member today.

If you have a family member or dear friend with Down syndrome, this webinar is for you! Not a Member? Join today! THANK YOU for supporting GLOBAL and our important work!